Top Midwest universities line up for 2020 Drug Development conference

News

OMAHA, Neb. (February 11, 2020)—With eight months before the third MidWest Drug Development Conference opens its doors, 11 Universities are already lined up to participate in the two-day event.

So far, the impressive list of participating institutions are:

  • Mayo Clinic
  • Ohio State University
  • Purdue University
  • University of Colorado Anchutz Medical Campus
  • University of Iowa
  • University of Kansas
  • University of Kentucky
  • University of Missouri
  • University of Nebraska Medical Center
  • University of Oklahoma
  • WARF (Wisconsin Alumni Research Foundation)

Each participating institution will highlight new therapeutics they are developing. All told, the two-day conference will feature about 40 therapeutics during 10-minute presentations. Specific details about those presentations are not yet available, but a list of previous technology presentation titles can he viewed here: https://www.mwdrugdevelopment.com/previoustechnologies/.

The 11 institutions account for a massive amount of research and innovation in the region, according to the latest data from the Association of University Technology Managers, or AUTM for short. In 2018 the participating universities spent a combined $6.05 billion in research, which led to 2,625 new inventions. The 11 schools secured 685 U.S. patents, produced 186 new products and formed 89 startup companies. They also signed 998 licensing agreements, 25 of which were worth more than $1 million each.

Additional institutions will likely join the list in the coming weeks.

Another key feature of the conference are one-on-one partnering meetings between researchers, tech transfer professionals, industry representatives, investors and other interested parties. Previous attendees have included representatives from such companies as AbbVie Ventures, Atlas Ventures, GlaxoSmithKline, Merck and Pfizer, to name a few.

The conference begins on Monday, Oct. 5, and concludes the following day, Tuesday, Oct. 6. It will be at the Capital District Marriott in downtown Omaha.

Cost is $500 per ticket, but organizers will waive a limited number of registration fees for those who represent pharmaceutical and biotech companies and investment groups. Contact conference organizers to learn how to receive a waiver code. Register here: https://www.mwdrugdevelopment.com/tickets/.

A full list of participating universities—and the technologies they plan to present—will soon be announced.

Comments are closed.